Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Solid Biosciences Inc. (SLDB) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Solid Biosciences Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1707502.
Total stock buying since 2018: $113,528,546.
Total stock sales since 2018: $10,125,400.
Total stock option exercises since 2018: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 1,254,405 | $5,949,164 | 4,217 | $16,295 | 24,668 | $0 |
| 2024 | 4,315,973 | $23,869,687 | 32,174 | $195,206 | 115,917 | $0 |
| 2023 | 0 | $0 | 32,312 | $99,833 | 134,369 | $0 |
| 2022 | 0 | $0 | 53,632 | $59,003 | 48,626 | $0 |
| 2021 | 4,815,380 | $27,688,434 | 68,341 | $546,875 | 70,000 | $0 |
| 2020 | 0 | $0 | 27,787 | $67,224 | 87,600 | $0 |
| 2019 | 2,822,581 | $13,125,001 | 477,000 | $5,108,371 | 0 | $0 |
| 2018 | 2,320,000 | $42,896,260 | 130,340 | $4,032,593 | 1,689,444 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 0 | $0 | 4,573 | $0 |
| 2025-04 | 0 | $0 | 0 | $0 | 4,574 | $0 |
| 2025-03 | 1,860 | $9,924 | 0 | $0 | 0 | $0 |
| 2025-02 | 1,252,545 | $5,939,240 | 0 | $0 | 0 | $0 |
| 2025-01 | 0 | $0 | 4,217 | $16,295 | 15,521 | $0 |
| 2024-12 | 0 | $0 | 23,573 | $132,007 | 60,764 | $0 |
| 2024-10 | 0 | $0 | 2,923 | $18,999 | 13,005 | $0 |
| 2024-07 | 0 | $0 | 0 | $0 | 3,255 | $0 |
| 2024-06 | 1,100 | $8,441 | 0 | $0 | 0 | $0 |
| 2024-05 | 0 | $0 | 462 | $4,772 | 1,553 | $0 |
| 2024-04 | 0 | $0 | 0 | $0 | 3,256 | $0 |
| 2024-01 | 4,314,873 | $23,861,246 | 5,216 | $39,428 | 34,084 | $0 |
| 2023-12 | 0 | $0 | 29,861 | $82,760 | 74,234 | $0 |
| 2023-10 | 0 | $0 | 0 | $0 | 15,569 | $0 |
| 2023-09 | 0 | $0 | 0 | $0 | 1,583 | $0 |
| 2023-07 | 0 | $0 | 0 | $0 | 15,570 | $0 |
| 2023-06 | 0 | $0 | 0 | $0 | 1,583 | $0 |
| 2023-05 | 0 | $0 | 487 | $2,363 | 1,553 | $0 |
| 2023-04 | 0 | $0 | 0 | $0 | 15,569 | $0 |
| 2023-03 | 0 | $0 | 0 | $0 | 1,584 | $0 |
| 2023-01 | 0 | $0 | 1,964 | $14,710 | 7,124 | $0 |
| 2022-07 | 0 | $0 | 0 | $0 | 24,313 | $0 |
| 2022-04 | 0 | $0 | 0 | $0 | 24,313 | $0 |
| 2022-03 | 0 | $0 | 53,169 | $58,485 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-06 | Smith Ian F | Option Ex | 4,573 | .00 | 0 |
| 2025-04-06 | Smith Ian F | Option Ex | 4,574 | .00 | 0 |
| 2025-03-11 | Kahn Clare | Buy | 1,860 | 5.34 | 9,924 |
| 2025-02-19 | Bcls Ii Equity Opportunities Gp, Llc | Buy | 1,000,000 | 4.03 | 4,030,000 |
| 2025-02-18 | Gross Phillip | Buy | 252,545 | 7.56 | 1,909,240 |
| 2025-01-28 | Ganot Ilan | Sale | 144 | 3.11 | 447 |
| 2025-01-27 | Ganot Ilan | Option Ex | 4,271 | .00 | 0 |
| 2025-01-10 | Tan Kevin (CFO & Treasurer) | Sale | 4,073 | 3.89 | 15,848 |
| 2025-01-09 | Tan Kevin (CFO & Treasurer) | Option Ex | 11,250 | .00 | 0 |
| 2024-12-03 | Herzich Paul (Chief Technology Officer) | Sale | 2,777 | 5.60 | 15,551 |
| 2024-12-03 | Hanrahan Jessie (Chief Regulatory Officer) | Sale | 4,610 | 5.60 | 25,820 |
| 2024-12-03 | Cumbo Alexander (President and CEO) | Sale | 11,114 | 5.60 | 62,238 |
| 2024-12-03 | Howton David T (Chief Operating Officer) | Sale | 5,072 | 5.60 | 28,398 |
| 2024-12-02 | Herzich Paul (Chief Technology Officer) | Option Ex | 7,239 | .00 | 0 |
| 2024-12-02 | Hanrahan Jessie (Chief Regulatory Officer) | Option Ex | 11,862 | .00 | 0 |
| 2024-12-02 | Cumbo Alexander (President and CEO) | Option Ex | 28,612 | .00 | 0 |
| 2024-12-02 | Howton David T (Chief Operating Officer) | Option Ex | 13,051 | .00 | 0 |
| 2024-10-21 | Brooks Gabriel (Chief Medical Officer) | Sale | 2,923 | 6.50 | 18,999 |
| 2024-10-18 | Brooks Gabriel (Chief Medical Officer) | Option Ex | 9,750 | .00 | 0 |
| 2024-10-03 | Smith Ian F | Option Ex | 3,255 | .00 | 0 |
| 2024-07-03 | Smith Ian F | Option Ex | 3,255 | .00 | 0 |
| 2024-06-07 | Kahn Clare | Buy | 1,100 | 7.67 | 8,441 |
| 2024-05-02 | Ganot Ilan | Sale | 462 | 10.33 | 4,772 |
| 2024-05-02 | Ganot Ilan | Option Ex | 1,553 | .00 | 0 |
| 2024-04-03 | Smith Ian F | Option Ex | 3,256 | .00 | 0 |
| 2024-01-29 | Ganot Ilan | Sale | 139 | 7.99 | 1,110 |
| 2024-01-27 | Ganot Ilan | Option Ex | 4,271 | .00 | 0 |
| 2024-01-11 | Ra Capital Nexus Fund, L.p. | Buy | 904,160 | 5.53 | 5,000,004 |
| 2024-01-11 | Edelman Joseph (Director) | Buy | 3,410,713 | 5.53 | 18,861,242 |
| 2024-01-09 | Tan Kevin (CFO & Treasurer) | Sale | 3,935 | 8.20 | 32,266 |
| 2024-01-09 | Tan Kevin (CFO & Treasurer) | Option Ex | 11,250 | .00 | 0 |
| 2024-01-03 | Ganot Ilan | Sale | 1,142 | 5.30 | 6,052 |
| 2024-01-03 | Ganot Ilan | Option Ex | 2,993 | .00 | 0 |
| 2024-01-03 | Smith Ian F | Option Ex | 15,570 | .00 | 0 |
| 2023-12-04 | Marlowe Jennifer (CSO) | Sale | 4,890 | 2.77 | 13,525 |
| 2023-12-04 | Herzich Paul (Chief Technology Officer) | Sale | 2,968 | 2.77 | 8,233 |
| 2023-12-04 | Hanrahan Jessie (Chief Regulatory Officer) | Sale | 4,879 | 2.78 | 13,563 |
| 2023-12-04 | Cumbo Alexander (President and CEO) | Sale | 11,757 | 2.77 | 32,519 |
| 2023-12-04 | Howton David T (Chief Operating Officer) | Sale | 5,367 | 2.78 | 14,920 |
| 2023-12-02 | Marlowe Jennifer (CSO) | Option Ex | 11,888 | .00 | 0 |
| 2023-12-02 | Herzich Paul (Chief Technology Officer) | Option Ex | 7,238 | .00 | 0 |
| 2023-12-02 | Hanrahan Jessie (Chief Regulatory Officer) | Option Ex | 11,862 | .00 | 0 |
| 2023-12-02 | Ganot Ilan | Option Ex | 1,583 | .00 | 0 |
| 2023-12-02 | Cumbo Alexander (President and CEO) | Option Ex | 28,612 | .00 | 0 |
| 2023-12-02 | Howton David T (Chief Operating Officer) | Option Ex | 13,051 | .00 | 0 |
| 2023-10-03 | Smith Ian F | Option Ex | 15,569 | .00 | 0 |
| 2023-09-02 | Ganot Ilan | Option Ex | 1,583 | .00 | 0 |
| 2023-07-03 | Smith Ian F | Option Ex | 15,570 | .00 | 0 |
| 2023-06-02 | Ganot Ilan (Director) | Option Ex | 1,583 | .00 | 0 |
| 2023-05-02 | Ganot Ilan (Director) | Sale | 487 | 4.85 | 2,363 |
| 2023-05-02 | Ganot Ilan (Director) | Option Ex | 1,553 | .00 | 0 |
| 2023-04-03 | Smith Ian F (Director) | Option Ex | 15,569 | .00 | 0 |
| 2023-03-02 | Ganot Ilan (Director) | Option Ex | 1,584 | .00 | 0 |
| 2023-01-27 | Morris Carl Ashley (Chief Scientific Officer) | Sale | 441 | 7.49 | 3,303 |
| 2023-01-27 | Morris Carl Ashley (Chief Scientific Officer) | Option Ex | 1,233 | .00 | 0 |
| 2023-01-27 | Ganot Ilan (Director) | Sale | 1,523 | 7.49 | 11,407 |
| 2023-01-27 | Ganot Ilan (Director) | Option Ex | 4,271 | .00 | 0 |
| 2023-01-03 | Smith Ian F (Director) | Option Ex | 1,620 | .00 | 0 |
| 2022-07-03 | Smith Ian F (Director) | Option Ex | 24,313 | .00 | 0 |
| 2022-04-03 | Smith Ian F (Director) | Option Ex | 24,313 | .00 | 0 |
| 2022-03-14 | Schneider Joel Solomon Zev (Chief Operating Officer) | Sale | 30,504 | 1.10 | 33,554 |
| 2022-03-14 | Morris Carl Ashley (Chief Scientific Officer) | Sale | 22,665 | 1.10 | 24,931 |
| 2022-02-10 | Ganot Ilan (CEO & President) | Sale | 463 | 1.12 | 518 |
| 2021-03-23 | Edelman Joseph (Director) | Buy | 2,608,695 | 5.75 | 14,999,996 |
| 2021-03-19 | Shah Rajeev M. | Buy | 2,206,685 | 5.75 | 12,688,438 |
| 2021-03-12 | Schneider Joel Solomon Zev (Chief Operating Officer) | Sale | 23,398 | 8.84 | 206,931 |
| 2021-03-12 | Morris Carl Ashley (Chief Scientific Officer) | Sale | 23,398 | 8.85 | 206,955 |
| 2021-02-12 | Ganot Ilan (CEO & President) | Sale | 457 | 7.66 | 3,501 |
| 2021-01-28 | Schneider Joel Solomon Zev (Chief Technology Officer) | Sale | 3,443 | 6.14 | 21,146 |
| 2021-01-28 | Morris Carl Ashley (Chief Scientific Officer) | Sale | 3,459 | 6.14 | 21,238 |
| 2021-01-28 | Ganot Ilan (CEO & President) | Sale | 10,713 | 6.14 | 65,777 |
| 2021-01-28 | Ziolkowski Jennifer Lynn (CFO, Treasurer & Asst. Secy) | Sale | 3,473 | 6.14 | 21,327 |
| 2021-01-27 | Schneider Joel Solomon Zev (Chief Technology Officer) | Option Ex | 11,500 | .00 | 0 |
| 2021-01-27 | Morris Carl Ashley (Chief Scientific Officer) | Option Ex | 11,500 | .00 | 0 |
| 2021-01-27 | Ganot Ilan (CEO & President) | Option Ex | 35,500 | .00 | 0 |
| 2021-01-27 | Ziolkowski Jennifer Lynn (CFO, Treasurer & Asst. Secy) | Option Ex | 11,500 | .00 | 0 |
| 2020-08-13 | Ganot Ilan (CEO & President) | Sale | 299 | 2.44 | 729 |
| 2020-08-12 | Ganot Ilan (CEO & President) | Option Ex | 800 | .00 | 0 |
| 2020-07-28 | Schneider Joel Solomon Zev (Chief Technology Officer) | Sale | 4,041 | 2.42 | 9,775 |
| 2020-07-28 | Morris Carl Ashley (Chief Scientific Officer) | Sale | 3,591 | 2.42 | 8,690 |
| 2020-07-28 | Ganot Ilan (CEO & President) | Sale | 11,124 | 2.42 | 26,908 |
| 2020-07-28 | Ziolkowski Jennifer Lynn (CFO, Treasurer & Asst. Secy) | Sale | 3,591 | 2.42 | 8,686 |
| 2020-07-28 | Herscha Lynette (Chief Legal Officer) | Sale | 5,141 | 2.42 | 12,436 |
| 2020-07-27 | Schneider Joel Solomon Zev (Chief Technology Officer) | Option Ex | 11,500 | .00 | 0 |
| 2020-07-27 | Morris Carl Ashley (Chief Scientific Officer) | Option Ex | 11,500 | .00 | 0 |
| 2020-07-27 | Ganot Ilan (CEO & President) | Option Ex | 35,500 | .00 | 0 |
| 2020-07-27 | Ziolkowski Jennifer Lynn (CFO, Treasurer & Asst. Secy) | Option Ex | 11,500 | .00 | 0 |
| 2020-07-27 | Herscha Lynette (Chief Legal Officer) | Option Ex | 16,000 | .00 | 0 |
| 2020-02-12 | Ganot Ilan (CEO & President) | Option Ex | 800 | .00 | 0 |
| 2019-07-25 | Edelman Joseph (10% Owner) | Buy | 2,822,581 | 4.65 | 13,125,001 |
| 2019-05-08 | Zarur Juan Andrey (Director) | Sale | 8,000 | 10.01 | 80,040 |
| 2019-03-28 | Boxer Capital, Llc (10% Owner) | Sale | 60,000 | 9.53 | 571,800 |
| 2019-03-27 | Boxer Capital, Llc (10% Owner) | Sale | 115,000 | 9.60 | 1,104,000 |
| 2019-03-26 | Boxer Capital, Llc (10% Owner) | Sale | 275,000 | 10.08 | 2,772,000 |
| 2019-01-14 | Arnold Matthew Bennett (Director) | Sale | 5,000 | 31.90 | 159,505 |
| 2019-01-07 | Arnold Matthew Bennett (Director) | Sale | 5,000 | 30.08 | 150,405 |
| 2019-01-04 | Amorrortu Pedro Alvaro (Chief Operating Officer) | Sale | 9,000 | 30.07 | 270,621 |
| 2018-12-03 | Amorrortu Pedro Alvaro (Chief Operating Officer) | Sale | 9,000 | 31.34 | 282,087 |
| 2018-12-03 | Quiroz Jorge Armando (Chief Medical Officer) | Sale | 40,150 | 30.95 | 1,242,642 |
| 2018-11-16 | Zarur Juan Andrey (Director) | Sale | 100 | 35.00 | 3,500 |
| 2018-11-16 | Quiroz Jorge Armando (Chief Medical Officer) | Sale | 100 | 34.90 | 3,490 |
| 2018-11-15 | Schneider Joel Solomon Zev (See Remarks) | Sale | 21,990 | 30.89 | 679,205 |
| 2018-11-15 | Amorrortu Pedro Alvaro (Chief Operating Officer) | Sale | 9,000 | 30.84 | 277,569 |
| 2018-11-15 | Ganot Ilan (CEO & President) | Sale | 50,000 | 30.88 | 1,544,100 |
| 2018-01-30 | Shah Rajeev M. | Buy | 1,000,000 | 16.00 | 16,000,000 |
| 2018-01-30 | Koppel Adam (Director) | Buy | 300,000 | 16.00 | 4,800,000 |
| 2018-01-30 | Edelman Joseph (10% Owner) | Buy | 1,020,000 | 21.66 | 22,096,260 |
| 2018-01-25 | Koppel Adam (Director) | Option Ex | 1,689,444 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of SLDB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Solid Biosciences Inc. (symbol SLDB, CIK number 1707502) see the Securities and Exchange Commission (SEC) website.